PuSH - Publication Server of Helmholtz Zentrum München

Basu, A.* ; Farsam, V.* ; Singh, K.* ; Crisan, D.* ; Treiber, N.* ; Schneider, L.A.* ; Huber, M.* ; Engelmeyer, J.I.* ; Schumacher, B.* ; Maity, P.* ; Brandt, D. ; Jastroch, M. ; Mauch, C.* ; Geiger, H.* ; Kletsas, D.* ; Scharffetter-Kochanek, K.*

Senescent fibroblasts drive melanoma progression through GCP-2 induced CREB phosphorylation enhancing glycolysis.

Aging Cell, 23:e70239 (2025)
Publ. Version/Full Text Research data DOI PMC
Open Access Gold
Creative Commons Lizenzvertrag
Aging constitutes the largest risk factor for melanoma progression. While a contribution of factors secreted from senescent skin fibroblasts to the progression of melanoma has been proposed, the nature of such factors and subsequent underlying mechanisms remains elusive. Here we show that the chemokine GCP-2 is excessively released by senescent fibroblasts in vitro and the skin of old melanoma patients. GCP-2 regulates, via phosphorylation of the transcription factor CREB at serine 133, defense-, cell cycle control-, and glycolysis-enhancing genes in melanoma cell lines. GCP-2 promotes oncogenic properties in vitro and in vivo in murine melanoma models. Inhibition of CREB phosphorylation in melanoma cells represses glycolytic target genes and induces a switch from glycolysis to oxidative phosphorylation that translates into a significant decline in tumor size in vivo in murine melanoma models. This study identifies a senescent fibroblast to chemokine to CREB to metabolic axis that drives melanoma progression. Targeting this axis may hold promise for novel therapeutic approaches in difficult-to-treat melanoma in older adults.
Altmetric
Additional Metrics?
[➜Log in]
Edit extra informations Login
Publication type Article: Journal article
Document type Scientific Article
Keywords Creb ; Gcp‐2 ; Sasp ; Melanoma Metabolism ; Melanoma Progression ; Senescent Fibroblast; Element-binding-protein; Granulocyte Chemotactic Protein-2; Human Breast-cancer; Cells In-vitro; Cxcr2 Antagonist; Growth; Resistance; Expression; Inhibition; Prognosis
ISSN (print) / ISBN 1474-9718
e-ISSN 1474-9726
Journal Aging Cell
Quellenangaben Volume: , Issue: , Pages: 23, Article Number: e70239 Supplement: ,
Publisher Wiley
Publishing Place 111 River St, Hoboken 07030-5774, Nj Usa
Reviewing status Peer reviewed
Institute(s) Institute of Diabetes and Obesity (IDO)
Grants Bundesministerium fr Bildung und Forschung
Deutsche Forschungsgemeinschaft
CRC1506]